Data as of Aug 29
| +0.19 / +0.16%|
The 2 analysts offering 12-month price forecasts for Bio-Rad Laboratories Inc have a median target of 139.00, with a high estimate of 150.00 and a low estimate of 128.00. The median estimate represents a +15.58% increase from the last price of 120.26.
The current consensus among 2 polled investment analysts is to Buy stock in Bio-Rad Laboratories Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.